Building Oligos Graphically

For many researchers, the process of acquiring custom oligonucleotides has never been more challenging. There are simply too many choices. For example, the increasing variety of specialty oligos, used in tasks ranging from diagnostics to sequencing, can make ordering a grueling and time-consuming task. And with a pool of more than 200 suppliers worldwide, choosing the right company for the job can be equally daunting. To help scientists obtain the best oligo for the task at hand, Seattle-based D

Written bySarah Goforth
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The company collaborates with a select group of vendors, known as the Synthesis Network, each with a specialty such as high-volume primers or oligos with modifications such as internal tags or labels. "We've carefully looked at the suppliers out there and chosen those who are the best at what they do," says company spokesman David Hensel, adding that as techniques advance, new suppliers will be added to supply them. Once OligoEngine receives an order, the system automatically determines which of its partner suppliers would be best suited to synthesize the oligos and processes the request.

The most distinctive feature of OligoEngine is its interface, an interactive menu-based system that allows researchers to type or paste in sequences, seeing a visual representation as they go. The user can use pull-down menus to define specific parameters such as chimeric alterations and internal modifications, eliminating the need for familiarity with each supplier's unique ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies